Status:
COMPLETED
Evaluating the Efficacy and Feasibility of a Novel Wireless ECG Recording System in Monitoring Patients After Atrial Fibrillation Ablation Procedure
Lead Sponsor:
The Cleveland Clinic
Conditions:
Persistent Atrial Fibrillation
Paroxysmal Atrial Fibrillation
Eligibility:
All Genders
Brief Summary
The investigators goal in this study is to examine the feasibility and efficacy of AliveCor iphone case monitoring device in monitoring patients after AF ablation by comparing transmissions using Aliv...
Eligibility Criteria
Inclusion
- Male or female between \> 18 and \< 75 years of age
- Paroxysmal or persistent atrial fibrillation
- Scheduled to undergo an AF ablation procedure
- Already has iPhone 4 or iPhone 4S with data plan
- Willing to use the iPhone Alive Cor case
- Written informed consent
Exclusion
- Unable or unwilling to use the Alive Cor case for their iPhone or iPhone 4S
- Residing outside the United States
Key Trial Info
Start Date :
June 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01912911
Start Date
June 1 2013
End Date
June 1 2014
Last Update
August 7 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic HVI
Cleveland, Ohio, United States, 44195